Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
Argenx presents data from ADHERE trial evaluating Vyvgart Hytrulo » 05:33
04/16/24
04/16
05:33
04/16/24
05:33
ARGX

Argenx

$376.12 /

-1.97 (-0.52%)

Argenx announced that…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Conference/Events
Cantor Fitzgerald biotech analysts to hold an analyst/industry conference call » 11:09
04/10/24
04/10
11:09
04/10/24
11:09
ARGX

Argenx

$382.21 /

-1.72 (-0.45%)

Biotech Analysts discuss…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Initiation
Immunovant initiated with bullish view at Oppenheimer, here's why » 16:07
03/27/24
03/27
16:07
03/27/24
16:07
IMVT

Immunovant

$32.25 /

+0.84 (+2.67%)

, ARGX

Argenx

$397.47 /

+0.165 (+0.04%)

Oppenheimer initiated…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Hot Stocks
Argenx advances clinical development of efgartigimod » 05:21
03/27/24
03/27
05:21
03/27/24
05:21
ARGX

Argenx

$397.31 /

-1.115 (-0.28%)

Argenx announced its plan…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Recommendations
Argenx price target raised by $6 at Scotiabank, here's why » 07:58
03/26/24
03/26
07:58
03/26/24
07:58
ARGX

Argenx

$398.42 /

-4.47 (-1.11%)

Scotiabank analyst George…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Hot Stocks
Argenx announces MHLW approval of Vyvgart » 05:26
03/26/24
03/26
05:26
03/26/24
05:26
ARGX

Argenx

$398.42 /

-4.47 (-1.11%)

Argenx announced that…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Over a month ago
On The Fly
Roche’s mixed myasthenia gravis data sending these stocks in opposite directions » 10:54
03/21/24
03/21
10:54
03/21/24
10:54
RHHBY

Roche

$32.62 /

+0.5 (+1.56%)

, TRML

Tourmaline Bio

$26.25 /

-18.42 (-41.24%)

, ARGX

Argenx

$396.01 /

+39.705 (+11.14%)

, IMVT

Immunovant

$32.58 /

+1.03 (+3.26%)

Roche (RHHBY) and Chugai…

Hot Stocks
Immunovant rallies after Chugai myasthenia gravis study failure » 08:12
03/21/24
03/21
08:12
03/21/24
08:12
IMVT

Immunovant

$31.55 /

+0.47 (+1.51%)

, RHHBY

Roche

$32.62 /

+0.5 (+1.56%)

, ARGX

Argenx

$356.31 /

-3.025 (-0.84%)

Shares of Immunovant…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Hot Stocks
Argenx rallies after Chugai generalized myasthenia gravis study fails » 07:15
03/21/24
03/21
07:15
03/21/24
07:15
ARGX

Argenx

$356.31 /

-3.025 (-0.84%)

, RHHBY

Roche

$32.62 /

+0.5 (+1.56%)

Shares of Argenx (ARGX)…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Recommendations
Argenx price target raised by EUR 12 at Morgan Stanley » 14:54
03/15/24
03/15
14:54
03/15/24
14:54
ARGX

Argenx

$373.80 /

-4.89 (-1.29%)

Morgan Stanley raised the…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Recommendations
Argenx price target lowered by EUR 20 at JPMorgan » 14:55
03/05/24
03/05
14:55
03/05/24
14:55
ARGX

Argenx

$386.22 /

-3.975 (-1.02%)

JPMorgan analyst James…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Recommendations
Argenx price target raised by $70 at Truist, here's why » 07:13
03/05/24
03/05
07:13
03/05/24
07:13
ARGX

Argenx

$390.19 /

-3.67 (-0.93%)

Truist raised the…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Recommendations
Argenx price target raised by $10 at Guggenheim, here's why » 07:50
03/01/24
03/01
07:50
03/01/24
07:50
ARGX

Argenx

$380.49 /

-17.12 (-4.31%)

Guggenheim raised the…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Recommendations
Argenx price target raised by $56 at Scotiabank, here's why » 07:08
03/01/24
03/01
07:08
03/01/24
07:08
ARGX

Argenx

$380.49 /

-17.12 (-4.31%)

Scotiabank raised the…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Recommendations
Argenx price target lowered by $15 at Baird, here's why » 06:45
03/01/24
03/01
06:45
03/01/24
06:45
ARGX

Argenx

$380.49 /

-17.12 (-4.31%)

Baird lowered the…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Recommendations
Argenx price target raised by $9 at JMP Securities, here's why » 06:10
03/01/24
03/01
06:10
03/01/24
06:10
ARGX

Argenx

$380.49 /

-17.12 (-4.31%)

JMP Securities analyst…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Earnings
Argenx reports Q4 EPS ($1.68), consensus ($1.70) » 05:49
02/29/24
02/29
05:49
02/29/24
05:49
ARGX

Argenx

$397.61 /

-13.71 (-3.33%)

Reports Q4 revenue…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Hot Stocks
Argenx announces FDA acceptance of Vyvgart Hytrulo sBLA for priority review » 05:34
02/20/24
02/20
05:34
02/20/24
05:34
ARGX

Argenx

$392.81 /

-0.49 (-0.12%)

Argenx announced that the…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Initiation
Wolfe starts Argenx at Peer Perform, notes lowered 2024 investor expectations » 19:15
02/14/24
02/14
19:15
02/14/24
19:15
ARGX

Argenx

$389.84 /

+2.885 (+0.75%)

Wolfe Research analyst…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Initiation
Argenx initiated with neutral view at Wolfe Research » 16:15
02/14/24
02/14
16:15
02/14/24
16:15
ARGX

Argenx

$389.84 /

+2.885 (+0.75%)

Wolfe Research initiated…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Recommendations
Argenx price target raised by EUR 30 at Barclays » 14:11
02/13/24
02/13
14:11
02/13/24
14:11
ARGX

Argenx

$386.39 /

-6.485 (-1.65%)

Barclays raised the…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Recommendations
Immunovant remains attractive despite stock underperformance, says Wells Fargo » 12:47
02/12/24
02/12
12:47
02/12/24
12:47
IMVT

Immunovant

$35.39 /

-0.1 (-0.28%)

, ARGX

Argenx

$390.97 /

-10.525 (-2.62%)

Wells Fargo notes that…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Initiation
Dianthus initiated with bullish view at Evercore ISI, here's why » 08:13
01/31/24
01/31
08:13
01/31/24
08:13
DNTH

Dianthus

$19.38 /

+0.475 (+2.51%)

, SNY

Sanofi

$50.26 /

-0.0449 (-0.09%)

, ARGX

Argenx

$381.21 /

-3.615 (-0.94%)

Evercore ISI initiated…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Recommendations
Argenx price target raised by $4 at Piper Sandler, here's why » 07:25
01/26/24
01/26
07:25
01/26/24
07:25
ARGX

Argenx

$382.59 /

+14.735 (+4.01%)

Piper Sandler analyst…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Over a quarter ago
Downgrade
Kepler Cheuvreux gets more bearish on Argenx, downgrades shares » 05:29
01/24/24
01/24
05:29
01/24/24
05:29
ARGX

Argenx

$369.82 /

+5.09 (+1.40%)

Kepler Cheuvreux analyst…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Recommendations
Argenx price target raised by $3 at Piper Sandler, here's why » 07:30
01/18/24
01/18
07:30
01/18/24
07:30
ARGX

Argenx

$372.52 /

-5.58 (-1.48%)

Piper Sandler raised the…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Hot Stocks
Argenx announces MHLW approval for Vyvdura injection in Japan » 05:24
01/18/24
01/18
05:24
01/18/24
05:24
ARGX

Argenx

$372.52 /

-5.58 (-1.48%)

Argenx announced that…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Earnings
Argenx sees Q4 revenue $374M, consensus $358.94M » 05:59
01/08/24
01/08
05:59
01/08/24
05:59
ARGX

Argenx

$396.29 /

+7.705 (+1.98%)

"In 2023, we reached…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Earnings
Argenx sees FY23 revenue $1.2B, consensus $1.22B » 05:57
01/08/24
01/08
05:57
01/08/24
05:57
ARGX

Argenx

$396.29 /

+7.705 (+1.98%)

Argenx reported…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Recommendations
Argenx price target lowered by $110 at UBS, here's why » 07:44
01/05/24
01/05
07:44
01/05/24
07:44
ARGX

Argenx

$388.58 /

+6.55 (+1.71%)

UBS lowered the…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.